Feenstra KL - Search Results

1

Metabolism of the bisphosphonate ester U-91502 in rats.

Slatter JG, Feenstra KL, Hauer MJ, Kloosterman DA, Parton AH, Sanders PE, Scott G, Speed W. Slatter JG, et al. Among authors: feenstra kl. Drug Metab Dispos. 1996 Jan;24(1):65-73. Drug Metab Dispos. 1996. PMID: 8825192

2

Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.

Sun EL, Feenstra KL, Bell FP, Sanders PE, Slatter JG, Ulrich RG. Sun EL, et al. Among authors: feenstra kl. Drug Metab Dispos. 1996 Feb;24(2):221-31. Drug Metab Dispos. 1996. PMID: 8742235

3

Metabolism of a bisphosphonate ester (PNU-91638) in rat.

Slatter JG, Feenstra KL, Hauer MJ, Sanders PE, Vrbanac JJ, Scott G, Speed W. Slatter JG, et al. Among authors: feenstra kl. Xenobiotica. 1997 Oct;27(10):1039-51. doi: 10.1080/004982597240019. Xenobiotica. 1997. PMID: 9364741

4

Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.

Slatter JG, Schaaf LJ, Sams JP, Feenstra KL, Johnson MG, Bombardt PA, Cathcart KS, Verburg MT, Pearson LK, Compton LD, Miller LL, Baker DS, Pesheck CV, Lord RS 3rd. Slatter JG, et al. Among authors: feenstra kl. Drug Metab Dispos. 2000 Apr;28(4):423-33. Drug Metab Dispos. 2000. PMID: 10725311 Clinical Trial.

5

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sams JP, Johnson MG, Sanders PE, Hauer MJ, Fagerness PE, Stryd RP, Peng GW, Shobe EM. Slatter JG, et al. Among authors: feenstra kl. Drug Metab Dispos. 2001 Aug;29(8):1136-45. Drug Metab Dispos. 2001. PMID: 11454733 Clinical Trial.

6

Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog.

Slatter JG, Adams LA, Bush EC, Chiba K, Daley-Yates PT, Feenstra KL, Koike S, Ozawa N, Peng GW, Sams JP, Schuette MR, Yamazaki S. Slatter JG, et al. Among authors: feenstra kl. Xenobiotica. 2002 Oct;32(10):907-24. doi: 10.1080/00498250210158249. Xenobiotica. 2002. PMID: 12419019

7

Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.

Locuson CW, Ethell BT, Voice M, Lee D, Feenstra KL. Locuson CW, et al. Among authors: feenstra kl. Drug Metab Dispos. 2009 Mar;37(3):457-61. doi: 10.1124/dmd.108.025312. Epub 2008 Dec 12. Drug Metab Dispos. 2009. PMID: 19074522

8

Pharmacokinetics and brain distribution of amitraz and its metabolites in rats.

Hu SX, Benner CP, White JA, Martin RA, Feenstra KL. Hu SX, et al. Among authors: feenstra kl. Environ Toxicol Pharmacol. 2019 Jan;65:40-45. doi: 10.1016/j.etap.2018.11.005. Epub 2018 Nov 23. Environ Toxicol Pharmacol. 2019. PMID: 30503806 Free article.

9

Stability of Ketoprofen Methylester in Plasma of Different Species.

Hu SX, Ernst K, Benner CP, Feenstra KL. Hu SX, et al. Among authors: feenstra kl. Curr Drug Metab. 2021;22(3):215-223. doi: 10.2174/1389200221666201217141025. Curr Drug Metab. 2021. PMID: 33334282

10

Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of In Vitro Assays and Pharmacokinetic Data from the Literature.

Hu SX, Mazur CA, Feenstra KL. Hu SX, et al. Among authors: feenstra kl. Drug Metab Lett. 2019;13(2):123-131. doi: 10.2174/1872312813666191120094649. Drug Metab Lett. 2019. PMID: 31750810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters